DNB Asset Management AS Lowers Stock Holdings in Procter & Gamble Company (The) $PG

DNB Asset Management AS lowered its stake in Procter & Gamble Company (The) (NYSE:PG) by 15.6% during the third quarter, HoldingsChannel reports. The firm owned 464,339 shares of the company’s stock after selling 85,555 shares during the quarter. DNB Asset Management AS’s holdings in Procter & Gamble were worth $71,346,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently modified their holdings of PG. Czech National Bank boosted its holdings in shares of Procter & Gamble by 3.8% in the third quarter. Czech National Bank now owns 594,914 shares of the company’s stock valued at $91,409,000 after acquiring an additional 21,825 shares in the last quarter. Westerkirk Capital Inc. acquired a new stake in Procter & Gamble in the second quarter valued at about $4,796,000. Vega Investment Solutions boosted its holdings in Procter & Gamble by 1.3% in the 2nd quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock valued at $101,710,000 after purchasing an additional 8,500 shares in the last quarter. Triodos Investment Management BV increased its position in Procter & Gamble by 7.3% during the 3rd quarter. Triodos Investment Management BV now owns 255,095 shares of the company’s stock worth $39,195,000 after purchasing an additional 17,400 shares during the period. Finally, Jump Financial LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $7,891,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

Shares of PG opened at $163.67 on Friday. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $179.99. The stock has a market cap of $380.37 billion, a P/E ratio of 24.25, a PEG ratio of 5.46 and a beta of 0.38. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.49. The company has a 50-day moving average of $150.50 and a two-hundred day moving average of $151.03.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The business had revenue of $22.21 billion during the quarter, compared to analysts’ expectations of $22.36 billion. During the same period last year, the company posted $1.88 EPS. The company’s revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were given a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Friday, January 23rd. Procter & Gamble’s dividend payout ratio is currently 62.67%.

Wall Street Analyst Weigh In

PG has been the topic of a number of analyst reports. Piper Sandler started coverage on Procter & Gamble in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $150.00 price target on the stock. Jefferies Financial Group raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and upped their price target for the stock from $156.00 to $179.00 in a research note on Tuesday, December 16th. TD Cowen downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and increased their price target for the company from $150.00 to $156.00 in a report on Tuesday, January 27th. Barclays set a $155.00 target price on shares of Procter & Gamble in a research report on Friday, January 16th. Finally, Erste Group Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a report on Wednesday, February 18th. Fourteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $168.33.

Insider Buying and Selling at Procter & Gamble

In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of Procter & Gamble stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the sale, the insider directly owned 44,735 shares in the company, valued at $7,259,595.80. The trade was a 25.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Gary A. Coombe sold 36,093 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the transaction, the chief executive officer directly owned 34,994 shares in the company, valued at $5,680,576.02. The trade was a 50.77% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 343,069 shares of company stock valued at $54,545,448. 0.20% of the stock is owned by company insiders.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.